Mineral supplement tablets market was valued at $14.7 billion in 2025 and is projected to reach $25.9 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). The market is witnessing steady growth due to the rising prevalence of micronutrient deficiencies and increasing awareness of preventive healthcare globally. A study published by the National Center for Biotechnology Information indicates that nearly one-third of the global population suffers from micronutrient deficiencies, with iron deficiency being the most common. Furthermore, the World Health Organization (WHO) estimates that over 2 billion people globally are affected by deficiencies in essential minerals such as iron, calcium, and zinc. 

Microcarrier market was valued at $1.26 billion in 2025 and is projected to reach $3.5 billion by 2035, growing at a CAGR of 10.80% from 2026 to 2035. The rapid expansion of biologics and advanced therapy manufacturing primarily drives this growth, as microcarriers enable high-density cell culture at commercial scale. Increasing adoption of cell and gene therapies is further accelerating demand for efficient and scalable bioprocessing solutions. Additionally, the shift from traditional 2D culture systems to advanced 3D platforms is enhancing productivity and cost efficiency. Growing investments in biopharmaceutical R&D and manufacturing infrastructure are also supporting market expansion. Rising focus on regenerative medicine and novel applications such as cultured meat is creating new growth avenues.

Medical protective equipment market was valued at $47 billion in 2025 and is projected to reach $82 billion by 2035, growing at a CAGR of 5.70% during the forecast period (2026–2035). According to the World Health Organization highlights the importance of achieving zero healthcare-associated infections (HAIs) through enhanced infection prevention strategies. The research underscores the critical role of personal protective equipment (PPE) in reducing transmission risks within healthcare settings. It also emphasizes the need for stringent infection control protocols to address antimicrobial resistance and emerging pathogens. These findings are reinforcing the demand for medical protective equipment across hospitals and clinical environments. Furthermore, the rise in surgical procedures and the expansion of healthcare infrastructure in emerging economies are contributing to market growth. Increasing awareness around occupational safety for healthcare workers is also expected to support sustained demand over the long term.

Medical gloves market was valued at $10.5 billion in 2025 and is projected to reach $17.2 billion by 2035, expanding at a CAGR of 5.1% during the forecast period (2026–2035). Market growth is primarily driven by the increasing focus on infection prevention and control across global healthcare systems. In January 2026, the Centers for Disease Control and Prevention reported that approximately 1 in 31 hospital patients acquires at least one healthcare-associated infection during treatment. This highlights the persistent risk of infections in clinical settings and the critical need for stringent hygiene practices. As a result, the use of disposable medical gloves has become essential in minimizing cross-contamination. Furthermore, the rising number of surgical procedures and the expansion of healthcare infrastructure in emerging economies are significantly boosting market demand.

Marketing calendar software market was valued at $10.5 billion in 2025 and is projected to reach $27.3 billion by 2035, expanding at a CAGR of 10.1% during 2026–2035. According to the International Telecommunication Union, nearly 6 billion people about 75% of the global population were using the internet, with over 240 million new users added in 2025. This surge in digital connectivity has significantly increased the volume of online content and marketing campaigns. As a result, organizations are facing growing complexity in managing multi-channel marketing activities. Marketing calendar software is gaining traction as it helps streamline campaign planning and execution. These solutions improve team collaboration and ensure timely delivery across platforms. Businesses are also leveraging such tools to maintain consistency in messaging and optimize campaign performance. The increasing shift toward omnichannel marketing strategies is further driving demand for centralized planning solutions, supporting sustained market growth.

Infectious enteritis treatment market was valued at approximately $529.2 million in 2025 and is expected to reach around $1,051.4 million by 2035, registering a CAGR of 7.2% during the forecast period from 2026 to 2035. According to the World Health Organization (WHO), diarrhoeal disease remains a major global health challenge, with nearly 1.7?billion cases annually, often caused by intestinal infections that require clinical management. The disease burden, driven by pathogens such as E.?coli, Salmonella, and rotavirus, is a key factor fueling the growth of the Infectious Enteritis Treatment Market. The rising incidence of enteric infections, especially in pediatric populations and developing countries, is increasing demand for effective therapies. Common treatments include oral rehydration solutions (ORS), antibiotics, antivirals, probiotics, and supportive care. This high prevalence of infectious enteritis is driving the adoption of these therapies and shaping market expansion. The growing focus on pediatric care and emerging economies further reinforces the market’s growth trajectory.

Hypertrophic cardiomyopathy (HCM) therapeutics market was valued at $1.5 billion in 2025 and is projected to reach $2.8 billion by 2035, expanding at a CAGR of 6.4% from 2026 to 2035. Market growth is driven by the increasing global burden of cardiovascular diseases and the rising adoption of targeted pharmacological therapies. According to the World Health Organization (WHO), cardiovascular diseases account for nearly 20 million casualties annually, representing the leading cause of mortality worldwide. This growing prevalence is increasing the demand for effective long-term therapies for conditions such as hypertrophic cardiomyopathy, particularly in hospital and cardiology clinic settings.

Hyaluronidase market was valued at $1.8 billion in 2025 and is projected to reach $3.7 billion by 2035, expanding at a CAGR of 7.7% during the forecast period from 2026 to 2035. Market growth is driven by the increasing adoption of biologics and subcutaneous drug delivery systems across healthcare. According to the International Federation of Pharmaceutical Manufacturers & Associations, biologics account for more than 30% of global pharmaceutical pipelines, highlighting the growing reliance on advanced drug delivery technologies. Hyaluronidase plays a critical role in enhancing subcutaneous absorption of large molecule drugs, improving patient convenience and reducing hospital burden. Additionally, the rising demand for minimally invasive aesthetic procedures is significantly contributing to market expansion globally.

Human microbiome market was valued at $1.6 billion in 2025 and is projected to reach $3.9 billion by 2035, expanding at a CAGR of 9.7%. A major growth driver is the rising prevalence of chronic diseases worldwide. According to the account for nearly 74% of global deaths, increasing the need for preventive and long-term healthcare solutions. This trend is significantly boosting demand for microbiome-based interventions such as probiotics, prebiotics, and personalized nutrition. Growing awareness of gut health and its link to immunity and metabolic disorders is further supporting market expansion. Additionally, advancements in microbiome research and precision medicine are enabling targeted therapeutic approaches. As a result, the market is witnessing steady growth across both clinical and consumer health segments.

Histology and cytology market was valued at $11.2 billion in 2025 and is projected to reach $19.3 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. This growth is largely driven by the rising global burden of cancer and the increasing need for early diagnostic screening. According to the World Health Organization (WHO), cancer caused nearly 10 million casualties in 2022, highlighting the importance of timely diagnosis. Histology and cytology techniques play a critical role in detecting cancer and other diseases at early stages. The growing adoption of these diagnostic methods across hospitals and laboratories is improving patient outcomes. Additionally, advancements in digital pathology and automation are further supporting market expansion.